Minnesota AI and Utilization Review Bill advances in Senate Policy Committee

April 15, 2026

EGWP marketplace medicaid Medicare

Legislation introduced to address the use of AI when conducting utilization reviews was passed by the Senate Judiciary and referred to Senate Commerce and Consumer Protection Committee. Overall, the bill would ban the use of AI tools in all utilization and prior authorization reviews performed by health plans or their vendors. To date, the bill’s author has not been willing to consider amendments from the industry.

Separately, the Senate Commerce Chair has said he intended to offer amendments supported by stakeholders to limit the scope of the bill to not using AI alone for adverse determinations and to remove the private right of action provision.

The Committee’s hearing and the Chair’s amendments will be an important procedural moment for the bill as it moves through the legislative process, particularly given ongoing discussions around guardrails, oversight, and human involvement in utilization review decisions.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like